| Jennifer Ann Laisle, MOT/L | |
|
4350 Will Rogers Pkwy Ste 600, Oklahoma City, OK 73108-1808 | |
| (405) 514-1627 | |
| Not Available |
| Full Name | Jennifer Ann Laisle |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 4350 Will Rogers Pkwy Ste 600, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982475687 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 1376 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Ann Laisle, MOT/L 2707 S Loblolly Ln, Edmond, OK 73012-1301 Ph: (405) 514-1627 | Jennifer Ann Laisle, MOT/L 4350 Will Rogers Pkwy Ste 600, Oklahoma City, OK 73108-1808 Ph: (405) 514-1627 |
News Archive
Medication used to treat patients with type II diabetes activates sensors on brain cells that increase hunger, causing people taking this drug to gain more body fat, according to researchers at Georgia State University, Oregon Health and Science University, Georgia Regents University and Charlie Norwood Veterans Administration Medical Center.
"The Obama Administration, like the Bush Administration before it, is again trying to bring some sense to food aid, but prospects for reform are low," Isobel Coleman, a senior fellow for U.S. Foreign Policy and director of the Civil Society, Markets, and Democracy Initiative at the Council on Foreign Relations, writes in the council's "Democracy in Development" blog.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, announced today that the first patient has been dosed in Japan in a Nippon Kayaku sponsored Phase 1 study of apaziquone in bladder cancer.
Rules-Based Medicine, Inc. (RBM) today announced the Cancer Prevention and Research Institute of Texas (CPRIT) has granted it a Company Commercialization Award to expand and enhance the OncologyMAP™ program for discovery and development of novel diagnostic and prognostic cancer tests. The award of approximately $3 million will fund research and development to more than double the number of cancer-associated biomarker assays in RBM's new OncologyMAP™ product.
Antibiotics are still being over-prescribed by GPs in contravention of guidelines, potentially contributing to antibiotic-resistant "superbugs", research launched at the British Pharmaceutical Conference (BPC) in Manchester has shown.
› Verified 4 days ago
Jovan Pride, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5701 Se 74th St Ste G, Oklahoma City, OK 73135 Phone: 405-610-1909 Fax: 405-610-1910 | |
Tung Le, MOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3327 Nw 50th St, Oklahoma City, OK 73112 Phone: 405-946-7300 | |
Dr. Rachele Quinones, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6525 N Meridian Ave, Ste, Oklahoma City, OK 73116 Phone: 405-721-1115 | |
Keli A Boone, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1404 Nw 122nd St, Oklahoma City, OK 73114 Phone: 405-749-8131 | |
Caroline Jean Grubbs, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6400 N Santa Fe Ave, Suite B, Oklahoma City, OK 73116 Phone: 405-840-2903 Fax: 405-840-3256 | |
Ms. Denise Lashaun Shaw, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2828 Nw 57th St Ste 302, Oklahoma City, OK 73112 Phone: 405-840-1253 | |
Kallie Kim, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4220 Se 34th St, Oklahoma City, OK 73165 Phone: 785-213-1894 |